GlassScriptPhysician profile
Lloyd S Hershman
NPI 1104803733
$1,205.58
in general payments reported to CMS, 2019-2025
20 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $387 · 2020: $599 · 2021: $180 · 2022: $39.69.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $295.13 | 2019-2020 | |
| Allergan, INC. | $188.65 | 2019-2020 | |
| Lilly USA, LLC | $144.64 | 2020-2021 | |
| Pfizer INC. | $86.10 | 2019-2021 | |
| Smith+Nephew, INC. | $84.83 | 2019-2020 | |
| Abbott Laboratories | $77.98 | 2021-2022 | |
| Sanofi-Aventis U.S. LLC | $69.87 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $54.49 | 2019-2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $24.56 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $19.99 | 2020 | |
| Kowa Pharmaceuticals America, INC. | $19.05 | 2020 | |
| E.R. Squibb & Sons, L.L.C. | $18.93 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $18.85 | 2019 | |
| Nestle Healthcare Nutrition INC. | $17.37 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $17.15 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eisai INC. | $16.91 | 2020 | |
| Esperion Therapeutics, INC. | $14.43 | 2021 | |
| Abbvie INC. | $13.83 | 2021 | |
| Xeris Pharmaceuticals, INC. | $11.69 | 2020 | |
| Gilead Sciences, INC. | $11.13 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lloyd Hershman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.